Free Trial

Waters (WAT) Stock Forecast & Price Target

Waters logo
$368.16 +7.53 (+2.09%)
(As of 12/20/2024 05:31 PM ET)

Waters - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
1
Hold
9
Buy
4

Based on 14 Wall Street analysts who have issued ratings for Waters in the last 12 months, the stock has a consensus rating of "Hold." Out of the 14 analysts, 1 has given a sell rating, 9 have given a hold rating, 3 have given a buy rating, and 1 has given a strong buy rating for WAT.

Consensus Price Target

$375.85
2.09% Upside
According to the 14 analysts' twelve-month price targets for Waters, the average price target is $375.85. The highest price target for WAT is $430.00, while the lowest price target for WAT is $312.00. The average price target represents a forecasted upside of 2.09% from the current price of $368.16.
Get the Latest News and Ratings for WAT and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Waters and its competitors.

Sign Up

WAT Analyst Ratings Over Time

TypeCurrent Forecast
12/23/23 to 12/22/24
1 Month Ago
11/23/23 to 11/22/24
3 Months Ago
9/24/23 to 9/23/24
1 Year Ago
12/23/22 to 12/23/23
Strong Buy
1 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
3 Buy rating(s)
3 Buy rating(s)
2 Buy rating(s)
0 Buy rating(s)
Hold
9 Hold rating(s)
10 Hold rating(s)
11 Hold rating(s)
8 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$375.85$365.85$318.50$287.78
Forecasted Upside2.09% Upside-2.04% Downside-6.24% Downside-12.73% Downside
Consensus Rating
Hold
Hold
Hold
Reduce
Vacuum up cash with these special trades? (Ad)

Have you ever heard about a “volatility vacuum?” Most people haven’t. It all revolves around this formula right here. Now, the most important thing is that this equation — when applied to certain tickers at a certain time each month —- can trigger these “volatility vacuums.” And when that happens, anyone has the shot at sucking out payouts of $290, $350, even $1,350 in as little as 24 hours. (With just a $1k starting stake!) Granted, there were smaller wins and those that did not work out but best of all, we can know exactly when these opportunities will hit. I’ve used this info to create a Cash Calendar that lays out the precise dates of these payouts.

And I’m sending it for FREE to anyone who joins me during my FREE training right here. 

WAT Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

WAT Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Waters Stock vs. The Competition

TypeWatersMedical CompaniesS&P 500
Consensus Rating Score
2.29
2.81
2.51
Consensus RatingHoldModerate BuyModerate Buy
Predicted Upside2.09% Upside25,827.32% Upside14.53% Upside
News Sentiment Rating
Neutral News

See Recent WAT News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
12/13/2024Bank of America
3 of 5 stars
 Boost TargetNeutral ➝ Neutral$400.00 ➝ $430.00+14.29%
11/4/2024Deutsche Bank Aktiengesellschaft
3 of 5 stars
 Boost TargetHold ➝ Hold$310.00 ➝ $325.00-15.59%
11/4/2024TD Cowen
5 of 5 stars
 Boost TargetHold ➝ Hold$363.00 ➝ $410.00+6.73%
11/4/2024Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetMarket Perform ➝ Market Perform$345.00 ➝ $360.00-6.29%
11/4/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHold ➝ Hold$332.00 ➝ $360.00-7.00%
11/4/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$340.00 ➝ $380.00-2.10%
11/4/2024Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
B. Couillard
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOverweight ➝ Overweight$380.00 ➝ $415.00+7.51%
11/4/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetUnderweight ➝ Underweight$330.00 ➝ $360.00-7.03%
10/17/2024Cfra
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Jonathan Sakraida
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Target$389.00+10.50%
10/8/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy$355.00 ➝ $415.00+18.60%
10/1/2024Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetIn-Line ➝ In-Line$335.00 ➝ $355.00-0.39%
8/1/2024Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
P. Souda
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Strong-Buy
8/1/2024Leerink Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeMarket Perform ➝ Outperform$325.00 ➝ $375.00+11.51%
7/31/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
M. Sykes
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold
5/8/2024Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral ➝ Neutral$319.00 ➝ $312.00-4.31%
12/13/2023Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoveragePeer Perform
12/11/2023Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$265.00 ➝ $300.00+2.69%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 02:48 PM ET.


WAT Forecast - Frequently Asked Questions

According to the research reports of 14 Wall Street equities research analysts, the average twelve-month stock price forecast for Waters is $375.85, with a high forecast of $430.00 and a low forecast of $312.00.

14 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Waters in the last year. There is currently 1 sell rating, 9 hold ratings, 3 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" WAT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in WAT, but not buy additional shares or sell existing shares.

According to analysts, Waters's stock has a predicted upside of 2.09% based on their 12-month stock forecasts.

Over the previous 90 days, Waters's stock had 1 upgrade by analysts.

Analysts like Waters less than other "medical" companies. The consensus rating for Waters is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how WAT compares to other companies.


This page (NYSE:WAT) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners